Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is -31.65% vs -15.15% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -96.46% vs 89.91% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is -73.44% vs 43.34% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 33.33% vs 0.00% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
Compare Quarterly Results Of Sichuan Goldstone Asia Pharmaceutical, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is -31.65% vs -15.15% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 26.18% vs -26.21% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -96.46% vs 89.91% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 104.26% vs -560.71% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -73.44% vs 43.34% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 204.84% vs -177.74% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 33.33% vs 0.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -20.00% vs -72.22% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






